Declaration of conformity drawn up for Inbiomotion MAFTEST®

Barcelona, July 13 2022, On 13 May 2022, the conformity assessment for the unique in vitro diagnostic medical device MAFTEST® developed by Inbiomotion was completed and the declaration of conformity was drawn up.

Read more…


By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...